Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of DW Silicone Hydrogel Lens Compared to DW Silicone Hydrogel Lens

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Be at least 18 years of age as of the date of evaluation for the study.~2. Not using any ocular medications~3. Have a self-reported full eye examination within 2 years.~4. Have:~   * read the Informed Consent~  * be given an explanation of the Informed Consent~  * indicate understanding of the Informed Consent~  * signed the Informed Consent document.~5. Be willing and able to adhere to the instructions set forth in this protocol and able to keep all specified appointments.~6. Be an adapted, current full-time silicone hydrogel or soft contact lens wearer. An adapted full-time wearer is defined as wearing contact lenses on a daily basis for at least 8 hours per day for at least one month prior to participation in the study.~7. Possess wearable and visually functional eyeglasses.~8. Be in good general health, based on his/her knowledge.~9. Require spectacle lens powers between -1.00 and -6.00 diopters sphere with no more than 0.75 diopter of refractive astigmatism in order to have the best spherical equivalent power of -6.50 or less.~10. Be willing to wear contact lenses in both eyes.~11. Have manifest refraction Snellen visual acuities (VA) equal to or better than 20/25 (less than or equal to LogMAR 0.10) in each eye.~12. Upon completing the fitting process with the lenses to be worn in the study, have contact lens Snellen VA equal to or better than 20/30 in each eye.~Exclusion Criteria:~1. Wearing lenses in a monovision modality and is unwilling to be fit with distance lenses in both eyes. NOTE: Subjects may not wear lenses in a monovision modality at any time during the study as it will interfere with the visual acuity analysis.~2. Any active participation in another one-day clinical trial within 7 days prior to this study or another dispensing trial within 30 days prior to this study.~3. Currently pregnant (to the best of the subject's knowledge), is lactating or is planning a pregnancy within the next month.~4. Has a known sensitivity to ingredients used in the over the counter contact lens care approved for use in the study.~5. Previous refractive surgery/anterior segment surgery; or current or previous orthokeratology treatment or irregular cornea.~6. Is aphakic or pseudophakic.~7. Unable to achieve a satisfactory fit with the lens designs used in the study~8. Ocular or systemic disease such as, but not limited to: anterior uveitis or iritis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, sclerodermia, keratoconus or type II diabetes.~9. The need for topical ocular medications or any medication which might contradict contact lens wear or which would require the lenses to be removed during the day.~10. The presence of clinically anterior segment infection, inflammations or abnormalities; such as iritis; or any infection of the eye, lids, or associated structures.~11. A history of herpetic keratitis.~12. A known history of corneal hypoesthesia (reduced corneal sensitivity) or active corneal ulcer, corneal infiltrates or fungal infection.~13. A history of papillary conjunctivitis that has interfered with contact lens wear.~14. Slit lamp findings that would contraindicate contact lens wear, including but not limited to:~    * Pathological dry eye or associated dry eye symptoms with decreased tear levels and punctuate staining \> grade 2~   * Pterygium~   * Corneal scars within the visual axis~   * Corneal edema or corneal staining ≥ grade 2~   * Neovascularization or ghost vessels \> 1.0 mm in from the limbus~   * Giant papillary conjunctivitis (GPC) of \> grade 2.~   * Seborrheic eczema, seborrheic conjunctivitis or blepharitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- enfilcon A + senofilcon A (Type: OTHER): Simultaneous wearing of daily wear contact lenses - investigational enfilcon A contact lenses in one eye and comparator senofilcon A worn in the other

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: safety issues